Review of Insulin Resistance in Dilated Cardiomyopathy and Implications for the Pediatric Patient Short Title: Insulin Resistance DCM and Pediatrics

Daniel Mak, Kaitlin A. Ryan, Joan C. Han

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations

Abstract

Energy metabolism in the heart is affected during states of dysfunction. Understanding how the heart utilizes substrates in cardiomyopathy may be key to the development of alternative treatment modalities. Myocardial insulin resistance has been proposed as a possible barrier to effective glucose metabolism in the heart. Extensive literature on the topic in adult individuals exists; however, review in the pediatric population is sparse. The pathophysiology of disease in children and adolescents is unique. The aim of this paper is to review the current knowledge on insulin resistance in dilated cardiomyopathy while also filling the gap when considering care in the pediatric population.

Original languageEnglish
Article number756593
JournalFrontiers in Pediatrics
Volume9
DOIs
StatePublished - 28 Oct 2021
Externally publishedYes

Keywords

  • SGLT-2 inhibitor
  • antidiabetic medications
  • dilated cardiomyopathy
  • insulin resistance
  • pediatric

Fingerprint

Dive into the research topics of 'Review of Insulin Resistance in Dilated Cardiomyopathy and Implications for the Pediatric Patient Short Title: Insulin Resistance DCM and Pediatrics'. Together they form a unique fingerprint.

Cite this